Geneos Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64K | Sell |
132
-221
| -63% | -$6.1K | ﹤0.01% | 2661 |
|
|
2025
Q1 | $10K | Sell |
353
-529
| -60% | -$15K | ﹤0.01% | 2566 |
|
|
2024
Q4 | $36.7K | Sell |
882
-1,212
| -58% | -$50.4K | ﹤0.01% | 1443 |
|
|
2024
Q3 | $140K | Buy |
2,094
+770
| +58% | +$51.5K | 0.01% | 866 |
|
|
2024
Q2 | $157K | Hold |
1,324
| – | – | 0.01% | 759 |
|
|
2024
Q1 | $141K | Sell |
1,324
-395
| -23% | -$42.1K | 0.01% | 778 |
|
|
2023
Q4 | $171K | Sell |
1,719
-284
| -14% | -$28.2K | 0.01% | 710 |
|
|
2023
Q3 | $207K | Buy |
2,003
+432
| +27% | +$44.6K | 0.01% | 676 |
|
|
2023
Q2 | $191K | Buy |
1,571
+50
| +3% | +$6.08K | 0.01% | 694 |
|
|
2023
Q1 | $234K | Sell |
1,521
-50
| -3% | -$7.68K | 0.01% | 620 |
|
|
2022
Q4 | $282K | Sell |
1,571
-444
| -22% | -$79.8K | 0.02% | 545 |
|
|
2022
Q3 | $238K | Sell |
2,015
-3,175
| -61% | -$375K | 0.02% | 556 |
|
|
2022
Q2 | $778K | Sell |
5,190
-5
| -0.1% | -$750 | 0.04% | 392 |
|
|
2022
Q1 | $894K | Buy |
5,195
+16
| +0.3% | +$2.75K | 0.04% | 384 |
|
|
2021
Q4 | $1.32M | Buy |
5,179
+166
| +3% | +$42.1K | 0.05% | 330 |
|
|
2021
Q3 | $1.71M | Hold |
5,013
| – | – | 0.07% | 270 |
|
|
2021
Q2 | $1.17M | Sell |
5,013
-467
| -9% | -$109K | 0.05% | 324 |
|
|
2021
Q1 | $988K | Sell |
5,480
-1,550
| -22% | -$279K | 0.03% | 426 |
|
|
2020
Q4 | $863K | Buy |
7,030
+2,759
| +65% | +$339K | 0.03% | 392 |
|
|
2020
Q3 | $296K | Buy |
4,271
+431
| +11% | +$29.9K | 0.02% | 567 |
|
|
2020
Q2 | $235K | Buy |
3,840
+1,207
| +46% | +$73.9K | 0.01% | 620 |
|
|
2020
Q1 | $79K | Buy |
+2,633
| New | +$79K | 0.01% | 927 |
|